Pharmaceutical Policy-2019: 25000 crore investment in Pharma industry in Haryana

Satish Handa, May 17
Notification approved for 25000 crore investment in pharmaceutical by the state government in Haryana state in March, 2019 remained unimplemented for a couple of months due to code of conducted declared in view of Lok Sabha polls in the country. Talking to media persons Narender Ahuja Chief Drug Controller Haryana said that immediate action is being taken in this proposal which would not only bring boom to industrial development in the field of pharmaceuticals in the state but also bring employment opportunities for 20000 youths. According to information, industry and commerce department has already completed plans in this regard and state government has also announced to develop a Pharma Park at Karnal with lab facilities to enable pharmacy college and university students to undertake research work and obtain not only experience certificate from industry but also financial aid to start own manufacturing unit in the state. He said, Karnal being nearer to capital Delhi and situated on Delhi-Mumbai rail corridor was selected as a suitable place to develop Pharma Park and Haryana state government has assured to provide full support to entrepreneurs as well as existing pharma companies to make investment in this proposed project in the state.
Chief Drug Controller, Haryana told The Financial World that youths in the state qualified in pharmacy education would be given preference in employment. He said that annual subsidy for amount worth Rs 36000 each will be given to industry providing job to females belonging to schedule caste and other backward classes, whereas the subsidy amount would be reduced to Rs 30000 annually in case of jobs provided to general category females. According to pharmaceutical policy, government would provide 25% subsidy on the purchase of machinery to the investors setting up manufacturing units in the state, besides loan facilities from nationalized banks up to Rs 50 lakh on which the interest would be charged on 50% loan amount. According to policy, there would be single window system for the investors setting up pharmaceutical industry in the state to deal all matters promptly and a cluster would be developed to assist entrepreneurs.
Ahuja told that there are 251 pharmaceutical manufacturing units presently functioning in Haryana state, which include 14 units given manufacturing licenses in past 18 months. He disclosed that as many as 29 fresh licenses were given in this period to manufacture cosmetic products with total number of 112 units manufacturing cosmetic products in the state.

See also  India records 782 crore UPI Transactions in Dec 2022

Related Posts

About The Author

Contact Us